Tivozanib

Tivozanib ATC Code L01EK03 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors - Tivozanib
Tivozanib
RoutesOral
FDA Approval Date2021-03-10
Molecular FormulaC22H19ClN4O5
Molecular Weight454.87 g/mol
CAS Number475108-18-0
Brand namesFotivda


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib